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Background: Metabolic risk factors and abnormalities such as obesity and hypertension are rapidly rising among
the Chinese population following China’s tremendous economic growth and widespread westernization of lifestyle
in recent decades. Limited information is available about the current burden of metabolic syndrome (MetS) in
China.
Methods: We analyzed data on metabolic risk factors among 22,457 adults aged ≥ 32 years participating in the
“Zhabei Health 2020” survey (2009–2010), a cross-sectional study of a representative sample of community residents
in Zhabei District. We defined MetS using Chinese-specific cut-off points for central obesity according to consensus
criteria recently endorsed by several international and national organizations in defining MetS in different
populations worldwide. We used a multiple logistic regression model to assess the associations of potential risk
factors with MetS.
Results: The unadjusted prevalence of the MetS was 35.1% for men and 32.5% for women according to the
consensus criteria for Chinese. The prevalence increased progressively from 12.1% among participants aged 32–45
years to 45.4% among those aged ≥ 75 years. Age, smoking, family history of diabetes, and education are
significantly associated with risk of MetS.
Conclusions: The MetS is highly prevalent and has reached epidemic proportion in Chinese urban adult
community residents.
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Lifestyle of the Chinese population is undergoing drastic
changes following China’s rapid economic growth in
recent decades. Westernization characterized by excess
energy intake and sedentary lifestyle is now becoming
widespread, especially among urban residents [1,2]. In
parallel, metabolic risk factors, such as obesity and
hypertension, are rising, and chronic diseases have
surpassed infectious diseases as the leading causes of
mortality and morbidity in China [2]. Indeed, cardiovas-
cular disease is now the number one killer in China and* Correspondence: lxl61@case.edu
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reproduction in any medium, provided the orthe prevalence of type 2 diabetes mellitus has tripled
during the last two decades and reached epidemic level,
with almost one out of 10 Chinese (9.7%) reporting
having been diagnosed with diabetes mellitus in a recent
national survey [3].
The metabolic syndrome (MetS), a clustering of meta-
bolic risk factors including hyperglycemia, dyslipidemia
(elevated triglycerides, reduced high-density lipopro-
teins), elevated blood pressure, and obesity (central adi-
posity in particular), is now a well recognized clinical
entity that may progress to overt diabetes mellitus and
increase risks of cardiovascular disease and certain can-
cers [4-6]. Insulin resistance resulting from long-term
energy imbalance is believed to play a critical role in the
pathogenesis of MetS [7]. While there is general agree-
ment in the medical community with regard to the
components of MetS, diagnostic criteria differ amongtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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on a cross-sectional national survey of 15,540 Chinese
adults aged 35–74 years in 2000–2001 reported 9.8%
prevalence rate of MetS in men and 17.8% in women
according to the US National Cholesterol Education Adult
Treatment Panel III (NCEP ATP III) criteria, with higher
rates in urban areas [11].
In an effort to harmonize the MetS diagnostic criteria,
the International Diabetes Federation (IDF) Task Force
on Epidemiology and Prevention and several other inter-
national and national authorities have recently issued a
joint interim consensus statement that recommends
population-specific cut-off points of waist circumference
for central obesity in defining the MetS [12]. The waist
circumference cut-off points for MetS recommended are
85 cm for Chinese men and 80 cm for women. These
cut-off points are much lower than the NCEP ATP III
obesity criteria (≥ 102 cm in men and ≥ 88 cm in
women). Thus, the prevalence of MetS in Chinese popu-
lation previously reported based on the NCEP ATP III
criteria is likely to have underestimated the burden of
MetS in China, [11] and the prevalence of MetS as
defined by the new consensus criteria in China urban
areas experiencing dramatic recent westernization of
health behaviors has not been reported.
We estimated the prevalence of MetS in adults par-
ticipating in a population-based study of community
residents living in Zhabei District of Shanghai, China.
The survey was conducted from February 2009 through
February 2010, and collected data on lifestyle and meta-
bolic risk factors on 22,757 adult participants 32 years
or older. We used the joint interim consensus criteria
by IDF and other organizations with Chinese specific
waist circumference cut-off points in defining the obes-
ity domain of the MetS [11]. Our study thus provides
the most current estimate of the prevalence of MetS
among urban residents in China. To facilitate comparison
with prior studies, we also estimated the prevalence
according to the modified NECP ATP III criteria [11,13].
Methods
Study population
The “Zhabei Health 2020” cross-sectional survey assessed
lifestyle and metabolic risk factors in permanent commu-
nity residents of all age selected from the entire population
living in Zhabei District, Shanghai. Located in north
Shanghai, Zhabei is one of the 9 urban districts of Shang-
hai city, with a total population of 703,526 permanent resi-
dents. Zhabei permanent residents were defined as
persons registered in the Zhabei District Census Bureau
who had not moved within the past five years. The survey
was conducted by the Zhabei Cooperative Group on Can-
cer Prevention and Treatment under the auspice of Zhabei
District Health Bureau.A multistage, stratified cluster sampling method was
used to select permanent residents for participation in
the survey. The sampling process was first stratified by
communities with the overall goal of an 8% sample of
the population. The target number of participants for
each of the 9 communities of Zhabei district was deter-
mined based on proportion of population residing in
each community. Next, streets or villages within each
community were randomly selected. Finally, buildings
within the selected streets or villages were randomly se-
lected. The survey was conducted via computer-assisted
personal interview (CAPI) at participants’ home in each
of the selected building. The overall response rate was
80.6%.
Residents who were 32 years and older (n=36,127)
were also invited to undergo a physical examinations. Of
these, 22,895 completed the CAPI survey, and 22,757
participants completed both the CAPI survey and physical
examination, representing a 63.0% completion rate of the
selected sample population. There were no statistically
significant differences in the age and gender distributions
between the respondents and the non-respondents. The
survey was approved by the Institutional Review Board of
Zhabei Cooperative Group of Cancer Prevention and
Treatment. Analysis of the survey data was approved by
the Institutional Review Board of University Hospitals
Case Medical Center.
Data collection
Data were collected via CAPI at the selected partici-
pants’ home by trained community health center staff.
The CAPI collected information on demographics,
personal and family medical history, and lifestyle risk
factors. The interview included questions related to the
diagnosis and treatment of diabetes, hypertension,
hyperlipidemia, and other chronic diseases. Behavioral
risk factor information such as smoking and alcohol
drinking was also collected.
All participants aged 32 years and older were invited
to undergo clinical physical examinations at local com-
munity health centers. Blood pressures were obtained
with the participant in the seated position after 5 minute
rest. Body weight and height were measured during the
examination without shoes and in light hospital clothing.
Waist circumference was measured at 1 cm above um-
bilicus, and hip circumference at the level of maximum
extension of the buttocks. Participants were instructed
to fast overnight before the scheduled clinical visit, and
samples of blood were obtained at the clinical visit next
morning. Collected samples of blood were put on wet ice
and immediately shipped to the central study laboratory
(Zhabei Shibei Hospital). Buffy coat, plasma and serum
were aliquoted and stored at -80°C until laboratory assays
could be done.
Wang et al. BMC Public Health 2013, 13:599 Page 3 of 9
http://www.biomedcentral.com/1471-2458/13/599Plasma glucose was measured with a modified hexoki-
nase enzymatic method. Lipid profile including total
cholesterol, HDL-C, low density lipoprotein cholesterol
(LDL-C), and triglycerides (TG) was analyzed in the
Central Biochemistry Laboratory of Linfeng Community
Health Center, Zhabei district.
Metabolic syndrome (MetS) definition
We used the recently published joint interim statement
endorsed by the International Diabetes Federation (IDF)
Task Force and several other international and national
organizations to define MetS [12]. The consensus criteria
define MetS as presence of three or more of the following
metabolic risk factors: 1) elevated waist circumference
(population- and country-specific cut-offs: ≥ 85 cm for
Chinese men and ≥ 80 cm for Chinese women); 2) ele-
vated triglycerides ≥ 150 mg/dL (1.69 mmol/L); 3) reduced
high density lipoprotein cholesterol (HDL-C) [< 40 mg/dL
(1.04 mmol/L) in men, and < 50 mg/dL (1.29 mmol/L) in
women]; 4) elevated blood pressure (systolic ≥ 130 mmHg
and/or diastolic ≥ 85 mmHg); and 5) elevated fasting
glucose ≥ 100 mg/dL (5.56 mmol/L). Individuals who
reported using drug treatments for any of above medical
conditions are considered met the criteria for the
specific component. For comparison, we also estimated
MetS using the modified NECP ATPIII criteria where
HDL-C < 40 mg/dL (1.04 mmol/L) and fasting glucose
≥ 110 mg/dL (6.1 mmol/L) were used as cut-off points
for both men and women to define low HDL and hyper-
glycemia, and waist circumference ≥ 90 cm and ≥ 80 cm
were used to define central obesity, respectively for men
and women [11,13].
Statistical analysis
For all baseline characteristics, means for continuous
variables and percentages for categorical variables were
calculated separately for men and women, and statistical
significances were examined by Student’s t-test and by
Chi-square test for continuous and categorical variables,
respectively. We calculated the distribution of partici-
pants who met the criteria for each of the 5 MetS do-
mains defined by the joint statement or by the modified
NCEP ATPIII. We then estimated the percentages of
participants met 0, 1, 2, 3, 4, or 5 MetS criteria. We next
estimated the total and sex specific prevalence of MetS
(met at 3 out of the 5 criteria) defined by the joint state-
ment or by the modified NCEP ATPIII. We compared
the difference between males and females using Chi-
square test. We also estimated the prevalence of MetS
according to age groups (32–44, 45–54, 55–64, 65–74,
and 75+), smoking status (yes or no), and levels of
education. Finally, we estimated odds ratios (ORs) and
95% confidence intervals (95% CIs) of MetS by age,
gender, family history of diabetes or coronary heartdiseases (CHD), smoking status, alcohol drinking in a
multiple logistic regression model. All statistical analyses
were performed using R 2.12.1, and all p values were
two sided with α = 0.05.
Results
Of the 22,757 adults who had completed clinical exams,
300 reported having been diagnosed with cancer and
were excluded, leaving 22,457 participants available for
the final analysis. Overall, 36.4% (38.1% men, and 35.3%
women) of the study participants were overweight or
obese (BMI ≥ 25 kg/m2), and 57.6% men and 54.0%
women were considered centrally obese according to the
interim consensus waist circumference measurements
for Chinese (Table 1). The self-reported prevalence of
diagnosed diabetes mellitus was 9.9% in men and 9.0%
in women. There was a striking gender-difference in
smoking and alcohol drinking: approximately half of the
male participants reported smoking cigarettes and over
one third of them reported drinking alcohol, while less
than 3% of females reported having either habit.
The distribution of MetS defining risk factors is shown
in Table 2. Noticeably, the prevalence rates of low HDL-C
and elevated fasting glucose and/or diagnosis of diabetes
were substantially higher in women and the prevalence
rates of elevated fasting glucose and/or diagnosis of
diabetes was substantially higher in men using the new
consensus criteria as compared to that using the modified
NCEP ATP III criteria. Over half of both men and women
were centrally obese or having elevated blood pressure or
hypertension. Table 3 shows the number and percentage
of participants met 0–5 MetS criteria according to the
consensus criteria or modified NCEP ATP III criteria.
Approximately one-third (33.9%) of the study population
met clinical diagnosis of MetS according to the consensus
criteria; even after excluding those with overt diabetes
mellitus or diagnosis of CHD, 29.1% of the study partici-
pants had MetS. The corresponding figures according
to the modified ATP III criteria were 23.8% and 18.8%
respectively.
Age is clearly a major determinant of MetS. The
proportion of participants met 2 or more MetS criteria
increased linearly with age in both men and women
regardless whether the consensus or the modified NCEP
ATP III criteria were used (Table 4). The prevalence of
MetS increased progressively from 12.1% for those aged
32–45 years to 45.4% for those aged 75 years or older.
Interestingly, the increase of the prevalence rate of MetS
with age was much steeper in women as compared with
men (Figure 1). The age-standardized (to the age distri-
bution of Shanghai population reported in 2009 census)
prevalence rate under joint interim census criteria was
31.5% (27.8% for women and 35.0% for men). Education
level and smoking also appear to be significant correlates
Table 1 Descriptive characteristics of “Health Zhabei 2020” survey adults (≥32 years)
Female (n=13565) Male (n=8892) P
ValueMean (SD) or No. (%) Mean (SD) or No. (%)
Age (years) 58.1(12.1) 59.7(12.2) <0.001
Education level ≤Middle school 8177(60.3) 4330(48.7) <0.001
High school or profession school 4357(32.1) 2996(33.6)
≥2-year college 1022(7.5) 1553(17.5)
missing 9(0.1) 13(0.2)
Smoking Yes 334(2.5) 4509(50.7) <0.001
No 13078(96.4) 4265(48.0)
missing 153(1.1) 118(1.3)
Alcohol Drinking Yes 392(2.9) 3057(34.4) <0.001
No 13020(96.0) 5717(64.3)
missing 153(1.1) 118(1.3)
Family History CHD 1127(8.3) 699(7.9) 0.230
Diabetes mellitus 845(6.2) 501(5.6) 0.065
Personal History CHD 852(6.3) 435(4.9) <0.001
Diabetes mellitus 1227(9.0) 884(9.9) 0.025
SBP (mmHg) 125.4(15.8) 128.5 (15.2) <0.001
DBP (mmHg) 79.1(8.9) 81.4(9.3) <0.001
BMI (kg/m2) 24.1(4.4) 24.2(3.9) 0.047
<25 8766(64.6) 5506(61.9) <0.001
25-30 4005(29.5) 3042(34.2)
>30 790(5.8) 342(3.9)
Waist Circumference (cm) 81.0(9.7) 86.4(9.2) <0.001
Central obesitya 4521(33.3) 6989(78.6) <0.001
Waist-Hip Ratio 0.85(0.07) 0.89(0.07) <0.001
Fasting Glucose (mg/dL) 97.3(27.0) 99.1(30.6) <0.001
Triglycerides (mg/dL) 132.9(106.3) 159.4(150.6) <0.001
HDL-C (mg/dL) 61.9(65.8) 54.1(65.8) <0.001
LDL-C (mg/dL) 116.0(34.8) 112.1(30.9) <0.001
Abbreviations: SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, HDL-C high density lipid cholesterol, LDL-C low density
lipid cholesterol.
aWaist ≥ 85 cm for men, ≥ 80 cm for women according to joint interim criteria.
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MetS was appreciably higher among those with middle
school or lower education as compared to those with
higher levels of education (Figure 2). Among smokers,
35.0% had MetS, and 32.0% of non-smokers had MetS.
Multiple logistic regression analysis revealed that age
(p < 0.01), smoking (p < 0.01), family history of diabetes
mellitus (p < 0.01), and low educational level (p < 0.01)
were positively and statistically significantly associated
with MetS. No association was found for gender, family
history of CHD or alcohol drinking (data not shown).
Discussion
In this large population-based study of community resi-
dents living in Zhabei District, Shanghai, approximately
one third of the participants had MetS according to the
joint interim consensus criteria recently endorsed by anumber of national and international organizations [12].
As expected, the prevalence rate was lower when the
modified ATPIII criteria were used to define MetS. The
prevalence of MetS was slightly higher in men than that
in women across all age groups, and increases linearly
with age. Similarly, each of the 5 MetS defining meta-
bolic risk factors was highly prevalent and increased
with age in this urban Chinese population.
It has been well documented that MetS is highly
prevalent world-wide, especially in affluent countries
[14-16]. Several previous studies have reported the
prevalence of MetS in Chinese population using various
criteria [11,17,18]. The report by Gu et al. based on a
national survey of Chinese adults aged 35–74 years
conducted in 2000–2001 reported that the age-
standardized prevalence of MetS was only 9.8% in men
and 17.8% in women according to the NCEP ATP III
Table 2 Prevalence of MetS components by gender according to the joint Interim consensus (IDF-C) and modified ATP
III (ATPIII-M) criteria
IDF-Ca [n(%)] ATP III-Mb [n(%)]
Female Male Female Male
Abdominal obesity 7328(54.0) 5120(57.6) 7328(54.0) 3195(35.9)
Elevated blood pressure or hypertension 7217(53.2) 5571(62.7) 7217(53.2) 5571(62.7)
Hypertriglyceridemia 4027(29.7) 3197(36.0) 4027(29.7) 3197(36.0)
Low HDL-C 3174(23.4) 1146(12.9) 683(5.0) 1146(12.9)
High fasting Glucose or Diabetes 3651(26.9) 2763(31.1) 2147(15.8) 1671(18.8)
aIDF-C (joint interim consensus criteria by IDF and other organization): Diabetes or fasting glucose ≥ 100 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥
85 mmHg; Dyslipidemia or HDL < 40 mg/dL for men and HDL < 50 mg/dL for women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 85 cm
for men and ≥ 80 cm for women.
bATP III-M (modified NCEP ATP III criteria): Diabetes or fasting glucose ≥ 110 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85 mmHg; Dyslipidemia or
HDL < 40 mg/dL for both men and women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 90 cm for men and ≥ 80 cm for women.
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using the modified NCEP ATP III criteria [11]. Another
survey of 16,442 adults (aged ≥18 years) conducted be-
tween August and October 2005 in Beijing reported
prevalence of 23.2% and 16.2% using the IDF and NCEP
ATP III criteria, respectively [17]. Another study of
5,584 adults (age = 20–79 years) conducted in 2008 in
Pudong New Area, a relatively affluent business district
in Shanghai, reported prevalence of 28.4% for men and
35.1% for women using the modified NCEP ATP III cri-
teria [18]. In the Shanghai Men’s Health Study by Villegas
R et al., the prevalence rate for men aged 40–74 years was
29.34% according to the modified NCEP ATP III criteria
for Asian populations [19]. Our present study based on a
large representative sample of urban community residents
in Zhabei District of Shanghai, a traditionally industrial-
ized district of Shanghai, used the currently recommended
gender-specific waist circumference cut-off points for
Chinese and showed high prevalence of MetS comparable
to that reported in Pudong New Area. For direct compari-
son, estimated age-standardized (to Shanghai 2009 census
counts) prevalence of MetS among those aged 35–74 yearsTable 3 Prevalence of MetS components according to the Inte
(ATP III-M) criteria
IDF-Ca [n(%)]
No. of Criteria met DM and CHD included DM and CHD e
Met 5 criteria 686(3.1) 382(2.0)
Met 4 criteria 2318(10.3) 1667(8.6
Met 3 criteria 4518(20.1) 3497(18.1
Met 2 criteria 5776(25.7) 5014(26.0
Met 1 criteria 5386(24.0) 5026(26.1
Met 0 criteria 3773(16.8) 3698(19.2
total 22457 19284
aIDF-C (joint interim consensus criteria by IDF and other organization): Diabetes or
85 mmHg; Dyslipidemia or HDL < 40 mg/dL for men and HDL < 50 mg/dL for wom
for men and ≥ 80 cm for women.
bATP III-M (modified NCEP ATP III criteria): Diabetes or fasting glucose ≥ 110 mg/dL
HDL < 40 mg/dL for both men and women; Dyslipidemia or Triglycerides ≥ 150 mgin our study using the modified NCEP ATP III definition
was 21.6% (23.7% in men and 19.4% in women), which
was still considerably higher than that reported by Gu
et al. Although the two surveys differed in the study design
and the targeted populations sampled, the higher preva-
lence of MetS in our study conducted in 2009–2010 in
Zhabei District of Shanghai, in conjunction with the
higher prevalence reported in the study conducted in 2008
in Pudong New Area of Shanghai, as compared to the
study by Gu et al. conducted in 2000–2001 may truly
indicate a rapidly rising trend of MetS in a short 8–9
year span, especially among urban Chinese population.
In support of this, several recent studies have also
reported substantial increase of overweight/obesity and
overt diabetes in China [3,20,21].
Insulin resistance is believed to be the underlying core
mechanistic feature of metabolic syndrome. Obesity, ab-
dominal adiposity in particular, plays an important role
in the pathogenesis of insulin resistance and metabolic
syndrome. An increasing number of comparative studies
showed that at given BMIs, metabolic responses were
greater in Asians as compared to Caucasians or USrim consensus (IDF-C) or the modified NCEP ATP III
ATP III-Mb [n(%)]








fasting glucose ≥ 100 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥
en; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 85 cm
; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85mmHg; Dyslipidemia or
/dL; Waist circumference ≥ 90cm for men and ≥ 80 cm for women.
Table 4 Prevalence of MetS component by gender according to the Interim consensus (IDF-C) or the modified NCEP ATP III (ATP III-M) criteria
Met 0 criteria Met 1 criteria Met 2 criteria Met 3 criteria Met 4 criteria Met 5 criteria
Gender Age [n(%)] [n(%)] [n(%)] [n(%)] [n(%)] [n(%)] Total
IDF-Ca ATPIII-Mb IDF-Ca ATPIII-Mb IDF-Ca ATPIII-Mb IDF-Ca ATPIII-Mb IDF-Ca ATPIII-Mb IDF-Ca ATPIII-Mb
32-44 693(46.5) 791(53.1) 456(30.6) 467(31.4) 219(14.7) 171(11.5) 86(5.8) 49(3.3) 31(2.1) 11(0.7) 4(0.3) 0(0.0) 1489
45-54 1145(24.5) 1344(28.8) 1368(29.3) 1558(33.3) 1076(23.0) 1062(22.7) 667(14.2) 539(11.5) 321(6.9) 155(3.3) 98(2.1) 17(0.4) 4675
Female 55-64 555(14.2) 657(16.8) 915(23.5) 1082(27.7) 1019(26.0) 1150(29.5) 814(20.9) 722(18.5) 448(11.5) 257(6.6) 153(3.9) 36(0.9) 3904
65-74 109(6.0) 121(6.6) 298(16.4) 387(21.2) 507(27.8) 605(33.2) 493(27.1) 511(28.1) 300(16.5) 174(9.6) 114(6.2) 23(1.3) 1821
≥75 66(3.9) 87(5.2) 271(16.2) 341(20.4) 472(28.2) 594(35.4) 490(29.2) 466(27.8) 277(16.5) 166(9.9) 100(6.0) 22(1.3) 1676
Total 2568(18.9) 3000(22.1) 3308(24.4) 3835(28.3) 3293(24.3) 3582(26.4) 2550(18.8) 2287(16.9) 1377(10.1) 763(5.6) 469(3.5) 98(0.7) 13565
32-44 253(29.4) 344(40.0) 256(29.7) 226(26.2) 187(21.7) 179(20.8) 111(12.9) 87(10.1) 43(5.0) 20(2.3) 11(1.3) 5(0.6) 861
45-54 409(16.9) 536(22.2) 545(22.5) 709(29.3) 636(26.3) 603(24.9) 518(21.4) 394(16.3) 253(10.5) 153(6.3) 58(2.4) 24(1.0) 2419
Male 55-64 328(11.2) 475(16.2) 678(23.1) 880(30.0) 827(28.2) 794(27.1) 684(23.4) 546(18.7) 337(11.5) 204(7.0) 76(2.6) 31(1.1) 2930
65-74 123(8.4) 173(11.8) 304(20.6) 450(30.5) 455(30.9) 435(29.5) 378(25.6) 298(20.2) 176(11.9) 97(6.6) 38(2.6) 21(1.4) 1474
≥75 92(7.6) 124(10.3) 295(24.4) 402(33.3) 378(31.3) 360(29.8) 277(23.0) 212(17.5) 132(10.9) 91(7.5) 34(2.8) 19(1.6) 1208
Total 1205(13.6) 1652(18.6) 2078(23.3) 2667(30.0) 2483(27.9) 2371(26.7) 1968(22.1) 1537(17.3) 941(10.6) 565(6.3) 217(2.5) 100(1.1) 8892
Overall 32-44 946(40.3) 1135(48.3) 712(30.3) 693(29.5) 406(17.3) 350(14.9) 197(8.4) 136(5.8) 74(3.1) 31(1.3) 15(0.6) 5(0.2) 2350
45-54 1554(21.9) 1880(26.5) 1913(27.0) 2267(32.0) 1712(24.1) 1665(23.5) 1185(16.7) 933(13.2) 574(8.1) 308(4.3) 156(2.2) 41(0.5) 7094
55-64 883(12.9) 1132(16.6) 1593(23.3) 1962(28.7) 1846(27.0) 1944(28.4) 1498(21.9) 1268(18.6) 785(11.5) 461(6.7) 229(3.4) 67(1.0) 6834
65-74 232(7.0) 294(8.9) 602(18.3) 837(25.4) 962(29.2) 1040(31.6) 871(26.4) 809(24.6) 476(14.5) 271(8.2) 152(4.6) 44(1.3) 3295
≥75 158(5.5) 211(7.3) 566(19.6) 743(25.8) 850(29.5) 954(33.1) 767(26.6) 678(23.5) 409(14.2) 257(8.9) 134(4.6) 41(1.4) 2884
Total 3773(16.8) 4652(20.7) 5386(24.0) 6502(29.0) 5776(25.7) 5953(26.5) 4518(20.1) 3824(17.0) 2318(10.3) 1328(5.9) 686(3.1) 198(0.9) 22457
aIDF-C (joint interim consensus criteria by IDF and other organization): Diabetes or fasting glucose ≥ 100 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85 mmHg; Dyslipidemia or HDL < 40 mg/dL for men and
HDL < 50 mg/dL for women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 85 cm for men and ≥ 80 cm for women.
bATP III-M (modified NCEP ATP III criteria): Diabetes or fasting glucose ≥ 110 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85 mmHg; Dyslipidemia or HDL < 40 mg/dL for both men and women; Dyslipidemia or




















%Figure 1 Prevalence of Metabolic Syndrome by Age and Gender, according to the Interim Consensus (IDF-C) and Modified NCEP ATP
III (ATP III-M) Criteria.
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gender-specific cut-off points of waist for central obesity
in the consensus definition of MetS [22-25]. A study
comparing data from the National Health and Nutrition
Survey (NHANES) III in US and from the Nutrition and
Health Survey in Taiwan further showed that Chinese
experienced much higher risk of hypertension, hypergly-
cemia, dyslipidemia, and hyperuricemia than US whites
and blacks at given BMIs [24]. This discrepancy is likely
due to a higher percentage of central body fat accumula-
tion in Asians than in Caucasians at fixed BMIs [23,26,27].
In our study, even among the 1,564 men with a waist cir-
cumference of larger than 85 cm (consensus cut-off point
for central obesity) but less than 90 cm (modified NCEP
ATP III cut-off point), the other 4 MetS defining meta-
bolic abnormalities are highly prevalent: 1,025 (65.5%)
having elevated blood pressure or hypertension, 654
(41.8%) having hypertriglyceridemia, 526 (33.0%) having
elevated fasting glucose or diabetes, and 273 (17.0%) hav-
ing low HDL-C. Thus, the use of the consensus criteria%
Figure 2 Prevalence of Metabolic Syndrome by Education and Gende
ATP III (ATP III-M) Criteria.with Chinese specific cut-off points for abdominal obesity
is a sensible measure of the true burden of MetS in China.
The MetS is known to significantly increase the risks
of diabetes and cardiovascular diseases. Even after ex-
cluding those with a known diagnosis of diabetes or
CHD, the prevalence of MetS was still as high as 29.1%
in our study population. At present, there is no national
screening program for metabolic risk factors in China.
Thus, it is conceivable that an alarmingly high propor-
tion of the general adult urban population in China
currently asymptomatic and without known diagnosis of
diabetes mellitus or CHD has undiagnosed MetS and is
not optimally managed for their metabolic abnormalities.
These persons are at great risk of progressing to full-
blown type 2 diabetes mellitus and of developing cardio-
vascular diseases. Indeed, a recent study has shown that
the prevalence of diabetes has tripled in the recent de-
cades in China [3]. Accumulating evidence also indicates
that obesity and MetS significantly increase the risks of
many cancers [28]. With the widespread urbanizationr, according to the Interim Consensus (IDF-C) and Modified NCEP
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growth, there is no sign of abating of upward trend of
obesity and MetS. Unchecked, it will certainly further
increase the burden of type 2 diabetes mellitus and other
chronic diseases in China.
There are a few limitations in our study. First, the com-
pletion rate of our study was modest at 63.0%, which
could to some extent have limited the generalizability of
our study results. However, comparison of age and gender
distribution between the respondents and the non-
respondents showed no statistically significant differences,
supporting that our study sample is a good representation
of the source population. Second, a cardinal feature of
MetS is insulin resistance or glucose intolerance. We did
not perform glucose tolerance test or directly measure
circulating levels of insulin or C-peptide in this study; as
such, some participants with impaired glucose tolerance
but normal fasting glucose levels could have been misclas-
sified. Nevertheless, elevated fasting glucose level is a com-
monly accepted criterion to define MetS.
Conclusions
Our study clearly indicates that MetS has become an
epidemic in China, and calls for immediate public health
measures for the intervention on metabolic risk factors
in the general Chinese population to reverse the rising
trend of MetS and obesity. Studies have documented the
efficacy of lifestyle and therapeutic interventions in
preventing the progression of impaired glucose intoler-
ance and MetS to overt diabetes and in reducing the risk
for cardiovascular diseases [29-31]. Reduction of metabolic
risk factors could be one of the most effective measures to
prevent diabetes, cardiovascular diseases and certain types
of cancer, and may have significant impact on the general
health of the Chinese population.
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